Landscape Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-84,686
Closed -$2.05M 782
2025
Q2
$2.05M Buy
84,686
+43,609
+106% +$1.02M 0.16% 206
2025
Q1
$1.04M Buy
41,077
+11,469
+39% +$300K 0.09% 289
2024
Q4
$786K Sell
29,608
-15,975
-35% -$433K 0.08% 311
2024
Q3
$1.32M Buy
+45,583
New +$1.33M 0.13% 215
2019
Q4
Sell
-43,705
Closed -$1.49M 786
2019
Q3
$1.49M Buy
+43,705
New +$1.59M 0.11% 203
2018
Q1
Sell
-18,559
Closed -$638K 620
2017
Q4
$638K Buy
+18,559
New +$633K 0.06% 333
2015
Q2
Sell
-25,928
Closed -$856K 747
2015
Q1
$856K Buy
+25,928
New +$824K 0.23% 97

Other funds holding PFE

Landscape Capital Management's PFE Position: Q3 2025 in Review

Landscape Capital Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 84,686 shares — an estimated $2.05M sold.

Landscape Capital Management first reported a position in PFE in Q1 2015 and held it in 7 quarters. The position peaked at $2.05M in Q2 2025. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Landscape Capital Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Landscape Capital Management sold 84,686 Pfizer shares in Q3 2025, an estimated $2.05M.
  • Landscape Capital Management first reported a position in Pfizer in Q1 2015 and held it in 7 quarters.
  • Landscape Capital Management's Pfizer position peaked at $2.05M in Q2 2025.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Landscape Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.